img

Global Tamsulosin Hydrochloride Sustained Release Capsules Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tamsulosin Hydrochloride Sustained Release Capsules Market Research Report 2024

According to QYResearch’s new survey, global Tamsulosin Hydrochloride Sustained Release Capsules market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tamsulosin Hydrochloride Sustained Release Capsules market research.
Key manufacturers engaged in the Tamsulosin Hydrochloride Sustained Release Capsules industry include Astellas Pharma Inc., Shenzhen Wanhe Pharmaceutical Co., Ltd., Zhejiang Conba Pharmaceutical Co., Ltd., Guangdong Huanan Pharmaceutical Group Co., Ltd., Hailisheng Group Co., Ltd., Shanghai Anbison Pharmaceutical Technology Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. and Sandoz Canada, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Tamsulosin Hydrochloride Sustained Release Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tamsulosin Hydrochloride Sustained Release Capsules market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tamsulosin Hydrochloride Sustained Release Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Astellas Pharma Inc.
Shenzhen Wanhe Pharmaceutical Co., Ltd.
Zhejiang Conba Pharmaceutical Co., Ltd.
Guangdong Huanan Pharmaceutical Group Co., Ltd.
Hailisheng Group Co., Ltd.
Shanghai Anbison Pharmaceutical Technology Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Sandoz Canada
Sanofi
Murli Krishna Pharma
DM Pharma
Segment by Type
Original Drug
Generic Drug

Segment by Application


Hospital
Clinic
Other

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Tamsulosin Hydrochloride Sustained Release Capsules report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Tamsulosin Hydrochloride Sustained Release Capsules Market Overview
1.1 Product Overview and Scope of Tamsulosin Hydrochloride Sustained Release Capsules
1.2 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Type
1.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Type (2024-2034)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Application
1.3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size Estimates and Forecasts
1.4.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2034
1.4.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2034
1.4.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Tamsulosin Hydrochloride Sustained Release Capsules Market Competition by Manufacturers
2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Manufacturers (2018-2024)
2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Manufacturers (2018-2024)
2.4 Global Tamsulosin Hydrochloride Sustained Release Capsules Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Product Type & Application
2.7 Tamsulosin Hydrochloride Sustained Release Capsules Market Competitive Situation and Trends
2.7.1 Tamsulosin Hydrochloride Sustained Release Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tamsulosin Hydrochloride Sustained Release Capsules Players Market Share by Revenue
2.7.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tamsulosin Hydrochloride Sustained Release Capsules Retrospective Market Scenario by Region
3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2018-2034
3.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2018-2024
3.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2024-2034
3.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2018-2034
3.3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2018-2024
3.3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2024-2034
3.4 North America Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.4.1 North America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2034)
3.4.3 North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.5.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2034)
3.5.3 Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2034)
3.6.3 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.7.1 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2034)
3.7.3 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2034)
3.8.3 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2034)
4.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2024)
4.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2024-2034)
4.1.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2034)
4.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2018-2034)
4.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2018-2024)
4.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2024-2034)
4.2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2018-2034)
4.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Price by Type (2018-2034)
5 Segment by Application
5.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2034)
5.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2024)
5.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2024-2034)
5.1.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2034)
5.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2018-2034)
5.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2018-2024)
5.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2024-2034)
5.2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application (2018-2034)
5.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Corporation Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Shenzhen Wanhe Pharmaceutical Co., Ltd.
6.2.1 Shenzhen Wanhe Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Shenzhen Wanhe Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.2.5 Shenzhen Wanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Zhejiang Conba Pharmaceutical Co., Ltd.
6.3.1 Zhejiang Conba Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Zhejiang Conba Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.3.5 Zhejiang Conba Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Guangdong Huanan Pharmaceutical Group Co., Ltd.
6.4.1 Guangdong Huanan Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Guangdong Huanan Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.4.5 Guangdong Huanan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Hailisheng Group Co., Ltd.
6.5.1 Hailisheng Group Co., Ltd. Corporation Information
6.5.2 Hailisheng Group Co., Ltd. Description and Business Overview
6.5.3 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.5.5 Hailisheng Group Co., Ltd. Recent Developments/Updates
6.6 Shanghai Anbison Pharmaceutical Technology Co., Ltd.
6.6.1 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Corporation Information
6.6.2 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.6.3 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.6.5 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.7 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
6.6.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.7.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.8.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.9 Sandoz Canada
6.9.1 Sandoz Canada Corporation Information
6.9.2 Sandoz Canada Description and Business Overview
6.9.3 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.9.5 Sandoz Canada Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Murli Krishna Pharma
6.11.1 Murli Krishna Pharma Corporation Information
6.11.2 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Description and Business Overview
6.11.3 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.11.5 Murli Krishna Pharma Recent Developments/Updates
6.12 DM Pharma
6.12.1 DM Pharma Corporation Information
6.12.2 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Description and Business Overview
6.12.3 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2024)
6.12.4 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.12.5 DM Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tamsulosin Hydrochloride Sustained Release Capsules Industry Chain Analysis
7.2 Tamsulosin Hydrochloride Sustained Release Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tamsulosin Hydrochloride Sustained Release Capsules Production Mode & Process
7.4 Tamsulosin Hydrochloride Sustained Release Capsules Sales and Marketing
7.4.1 Tamsulosin Hydrochloride Sustained Release Capsules Sales Channels
7.4.2 Tamsulosin Hydrochloride Sustained Release Capsules Distributors
7.5 Tamsulosin Hydrochloride Sustained Release Capsules Customers
8 Tamsulosin Hydrochloride Sustained Release Capsules Market Dynamics
8.1 Tamsulosin Hydrochloride Sustained Release Capsules Industry Trends
8.2 Tamsulosin Hydrochloride Sustained Release Capsules Market Drivers
8.3 Tamsulosin Hydrochloride Sustained Release Capsules Market Challenges
8.4 Tamsulosin Hydrochloride Sustained Release Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes) of Key Manufacturers (2018-2024)
Table 5. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Tamsulosin Hydrochloride Sustained Release Capsules Average Price (US$/Box) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Tamsulosin Hydrochloride Sustained Release Capsules, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tamsulosin Hydrochloride Sustained Release Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tamsulosin Hydrochloride Sustained Release Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2018-2024) & (K Boxes)
Table 18. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Region (2018-2024)
Table 19. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2024-2034) & (K Boxes)
Table 20. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Region (2024-2034)
Table 21. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Region (2018-2024)
Table 23. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Region (2024-2034)
Table 25. North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2024) & (K Boxes)
Table 27. North America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2024-2034) & (K Boxes)
Table 28. North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2024) & (K Boxes)
Table 32. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2024-2034) & (K Boxes)
Table 33. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2018-2024) & (K Boxes)
Table 37. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2024-2034) & (K Boxes)
Table 38. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2024) & (K Boxes)
Table 42. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2024-2034) & (K Boxes)
Table 43. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2024) & (K Boxes)
Table 47. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2024-2034) & (K Boxes)
Table 48. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes) by Type (2018-2024)
Table 51. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes) by Type (2024-2034)
Table 52. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2024)
Table 53. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2024-2034)
Table 54. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2018-2024)
Table 57. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2024-2034)
Table 58. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Type (2018-2024)
Table 59. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Type (2024-2034)
Table 60. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes) by Application (2018-2024)
Table 61. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes) by Application (2024-2034)
Table 62. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2024)
Table 63. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2024-2034)
Table 64. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application (2018-2024)
Table 67. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application (2024-2034)
Table 68. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Application (2018-2024)
Table 69. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Application (2024-2034)
Table 70. Astellas Pharma Inc. Corporation Information
Table 71. Astellas Pharma Inc. Description and Business Overview
Table 72. Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 73. Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 74. Astellas Pharma Inc. Recent Developments/Updates
Table 75. Shenzhen Wanhe Pharmaceutical Co., Ltd. Corporation Information
Table 76. Shenzhen Wanhe Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 78. Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 79. Shenzhen Wanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Zhejiang Conba Pharmaceutical Co., Ltd. Corporation Information
Table 81. Zhejiang Conba Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 83. Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 84. Zhejiang Conba Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Guangdong Huanan Pharmaceutical Group Co., Ltd. Corporation Information
Table 86. Guangdong Huanan Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 87. Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 88. Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 89. Guangdong Huanan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 90. Hailisheng Group Co., Ltd. Corporation Information
Table 91. Hailisheng Group Co., Ltd. Description and Business Overview
Table 92. Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 93. Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 94. Hailisheng Group Co., Ltd. Recent Developments/Updates
Table 95. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Corporation Information
Table 96. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Description and Business Overview
Table 97. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 98. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 99. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
Table 100. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
Table 101. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 103. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 104. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
Table 106. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 107. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 108. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 109. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 110. Sandoz Canada Corporation Information
Table 111. Sandoz Canada Description and Business Overview
Table 112. Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 113. Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 114. Sandoz Canada Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 118. Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Murli Krishna Pharma Corporation Information
Table 121. Murli Krishna Pharma Description and Business Overview
Table 122. Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 123. Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 124. Murli Krishna Pharma Recent Developments/Updates
Table 125. DM Pharma Corporation Information
Table 126. DM Pharma Description and Business Overview
Table 127. DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 128. DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product
Table 129. DM Pharma Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Tamsulosin Hydrochloride Sustained Release Capsules Distributors List
Table 133. Tamsulosin Hydrochloride Sustained Release Capsules Customers List
Table 134. Tamsulosin Hydrochloride Sustained Release Capsules Market Trends
Table 135. Tamsulosin Hydrochloride Sustained Release Capsules Market Drivers
Table 136. Tamsulosin Hydrochloride Sustained Release Capsules Market Challenges
Table 137. Tamsulosin Hydrochloride Sustained Release Capsules Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tamsulosin Hydrochloride Sustained Release Capsules
Figure 2. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Share by Type in 2022 & 2034
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size (2018-2034) & (US$ Million)
Figure 13. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales (2018-2034) & (K Boxes)
Figure 14. Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price (US$/Box) & (2018-2034)
Figure 15. Tamsulosin Hydrochloride Sustained Release Capsules Report Years Considered
Figure 16. Tamsulosin Hydrochloride Sustained Release Capsules Sales Share by Manufacturers in 2022
Figure 17. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Tamsulosin Hydrochloride Sustained Release Capsules Players: Market Share by Revenue in 2022
Figure 19. Tamsulosin Hydrochloride Sustained Release Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2034)
Figure 22. North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2034)
Figure 23. United States Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2034)
Figure 26. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2034)
Figure 27. Germany Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Region (2018-2034)
Figure 34. China Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Southeast Asia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2034)
Figure 42. Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2034)
Figure 43. Mexico Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Brazil Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Argentina Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Colombia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Tamsulosin Hydrochloride Sustained Release Capsules by Type (2018-2034)
Figure 53. Global Revenue Market Share of Tamsulosin Hydrochloride Sustained Release Capsules by Type (2018-2034)
Figure 54. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Type (2018-2034)
Figure 55. Global Sales Market Share of Tamsulosin Hydrochloride Sustained Release Capsules by Application (2018-2034)
Figure 56. Global Revenue Market Share of Tamsulosin Hydrochloride Sustained Release Capsules by Application (2018-2034)
Figure 57. Global Tamsulosin Hydrochloride Sustained Release Capsules Price (US$/Box) by Application (2018-2034)
Figure 58. Tamsulosin Hydrochloride Sustained Release Capsules Value Chain
Figure 59. Tamsulosin Hydrochloride Sustained Release Capsules Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed